Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

A novel mechanism of retinoic acid resistance in acute promyelocytic leukemia cells through a defective pathway in telomerase regulation

Abstract

Human telomerase, a cellular reverse transcriptase specifically activated in most malignant tumors and usually inactive in normal somatic cells, plays an important role in immortalization and tumorigenesis. Early reports have indicated that terminal differentiation of various cells is associated with a rapid inhibition of telomerase activity, preceded by a down-regulation of telomerase reverse transcriptase (hTERT) mRNA. Recently, we have shown that telomerase can be repressed by all-trans retinoic acid (ATRA) independently of terminal maturation during long-term ATRA treatment of the maturation-resistant promyelocytic leukemia cell line (NB4-R1), leading to shortening of telomeres and cell death, events overcome by ectopic hTERT expression. Here, we report the isolation of a variant of NB4-R1 cells (NB4-R1SFD), which bypasses this death step, because of a re-activated telomerase, despite the continuous presence of ATRA. While unresponsive to a long-term maturation independent regulation of telomerase by ATRA, these cells retain a functional pathway of telomerase down-regulation associated with retinoid-induced maturation. These findings reinforce the notion that two distinct pathways of telomerase regulation by retinoids co-exist in APL cells. Noteworthy, we show that the slow developing mechanism, that causes death of maturation-resistant cells, is subjected to a new type of retinoid-resistance as yet not understood.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Greider CW, Blackburn EH . A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis Nature 1989 337: 331–337

    Article  CAS  PubMed  Google Scholar 

  2. Nakamura TM, Cech TR . Reversing time: origin of telomerase Cell 1998 92: 587–590

    Article  CAS  PubMed  Google Scholar 

  3. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, Bachetti S . Telomeres shortening associated with chromosomal instability in immortal cells which express telomerase activity EMBO J 1992 11: 1921–1929

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsoop RC, Yu J, Le S, West MD, Harley CB, Andrews WH, Greider CW, Villeponteau B . The RNA component of human telomerase Science 1995 269: 1236–1241

    Article  CAS  PubMed  Google Scholar 

  5. Harrington L, McPhail T, Mar V, Zhou W, Oulton R Amgen EST Program Bass MB, Isabel A, Robinson MO . A mammalian telomerase-associated protein Science 1997 275: 973–977

    Article  CAS  PubMed  Google Scholar 

  6. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Linger J, Harley CB, Cech TR . Telomerase catalytic subunit homologs from fission yeast and human Science 1997 277: 955–959

    Article  CAS  PubMed  Google Scholar 

  7. Beattie TL, Zhou W, Robinson MO, Harrington L . Reconstitution of human telomerase activity in vitro Curr Biol 1998 8: 177–180

    Article  CAS  PubMed  Google Scholar 

  8. Poole JC, Andrews LG, Tollefsbol TO . Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT) Gene 2001 269: 1–12

    Article  CAS  PubMed  Google Scholar 

  9. Misiti S, Nanni S, Fontemaggi G, Cong Y-S, Wen J, Hirte HW, Piaggio G, Sacchi A, Pontecorvi A, Bachetti S, Farsetti A . Induction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cells Mol Cell Biol 2000 20: 3764–3771

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Kyo S, Takakura M, Kanaya T, Zhuo W, Fujimoto K, Nishio Y, Orimo A, Inoue M . Estrogen activates telomerase Cancer Res 1999 59: 5917–5921

    CAS  PubMed  Google Scholar 

  11. Sharma HW, Sokoloski JA, Perez JR, Maltese J-Y, Sartorelli AC, Stein CA, Nichols G, Khaled Z, Telang NT, Narayanan R . Differentiation of immortal cells inhibits telomerase activity Proc Natl Acad Sci USA 1995 92: 12343–12346

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Bestilny LJ, Brown CB, Miura Y, Robertson LD, Riabowol KT . Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines Cancer Res 1996 56: 3796–3802

    CAS  PubMed  Google Scholar 

  13. Xu D, Gruber A, Peterson C, Pisa P . Supression of telomerase activity in HL60 cells after treatment with differentiating agents Leukemia 1996 10: 1354–1357

    CAS  PubMed  Google Scholar 

  14. Albanell J, Wan W, Mellado B, Guanawardane R, Sher HI, Dmitrovsky E, Moore MAS . Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines Cancer Res 1996 56: 1503–1508

    CAS  PubMed  Google Scholar 

  15. Nason-Burchenal K, Maerz W, Albanell J, Allopenna J, Martin P, Moore MAS, Dmitrovsky E . Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization Differentiation 1997 61: 321–331

    Article  CAS  PubMed  Google Scholar 

  16. Yamada O, Takanashi M, Ujihara M, Mizoguchi H . Down-regulation of telomerase activity is an early event of cellular differentiation without apparent telomeric DNA change Leukemia Res 1998 22: 711–717

    Article  CAS  Google Scholar 

  17. Xu D, Gruber A, Björkholm M, Peterson C, Pisa P . Suppression of telomerase reverse transcriptase (hTERT) expression in differentiated HL-60 cells: regulatory mechanisms Cancer 1999 80: 1156–1161

    Article  CAS  Google Scholar 

  18. Gudas LJ, Sporn MB, Roberts AB . Cellular biology and biochemistry of the retinoids In: Sporn MB, Roberts AB, Goodman DS (eds) The Retinoids: Biology, Chemistry, and Medicine, 2nd edn Raven Press: New York 1994 pp 443–520

    Google Scholar 

  19. Smith MA, Parkinson DR, Cheson BD, Friedman MA . Retinoids in cancer therapy J Clin Oncol 1992 10: 839–864

    Article  CAS  PubMed  Google Scholar 

  20. Chambon P . A decade of molecular biology of retinoic acid receptors FASEB J 1996 10: 940–954

    Article  CAS  PubMed  Google Scholar 

  21. Lippman SM, Lotan R . Advances in the development of retinoids as chemopreventive agents J Nutr 2000 130: 4795–4825

    Article  Google Scholar 

  22. Lippman SM, Parkinson DR, Itri LM, Schantz SP, Ota DM, Schusterman MA, Krakoff IH, Gutterman JU, Hong WK . 13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin J Natl Cancer Inst 1992 84: 235–241

    Article  CAS  PubMed  Google Scholar 

  23. Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhao L, Gu RJ, Wang ZY . Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia Blood 1988 72: 567–572

    CAS  PubMed  Google Scholar 

  24. Castaigne S, Chomienne C, Daniel MT, Ballerini P, Berger R, Fenaux P, Degos L . All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results Blood 1990 76: 1704–1709

    CAS  PubMed  Google Scholar 

  25. Cornic M, Delva L, Guidez F, Balitrand N, Degos L, Chomienne C . Induction of retinoic acid-binding protein in normal and malignant human myeloid cells by retinoic acid in acute promyelocytic leukemia patients Cancer Res 1992 52: 3329–3334

    CAS  PubMed  Google Scholar 

  26. Shao W, Benedetti L, Lamph W, Nervi C, Miller W Jr . A retinoid-resistant acute promyelocytic leukemia subclone express a dominant negative PML-RARα mutation Blood 1997 89: 4282–4289

    CAS  PubMed  Google Scholar 

  27. Kitamura K, Kiyoi H, Yoshida H, Saito H, Ohno R, Naoe T . Mutant AF-2 domain of PML-RARα in retinoic acid-resistant NB4 cells: differentiation induced by RA is triggered directly through PML-RARα and its down-regulation in acute promyelocytic leukemia Leukemia 1997 11: 1950–1956

    Article  CAS  PubMed  Google Scholar 

  28. Imaizumi M, Suzuki H, Yoshinari M, Sato A, Saito T, Sugawara A, Tshuchiya S, Hatae Y, Fujimoto T, Kakizuka A, Konno T, Linuma K . Mutations in the E-domain of RARα portion of the PML-RARα chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia Blood 1998 92: 374–382

    CAS  PubMed  Google Scholar 

  29. Ding W, Li Y-P, Nobile LM, Grills G, Carrera I, Paietta E, Tallman MS, Wiernick PH, Gallagher E . Leukemic cellular retinoic acid resistance and missense mutations in the PML/RARα fusion gene after relapse of acute promyelocytic leukemia from treatment with all-trans retinoic acid and intensive chemotherapy Blood 1998 92: 1172–1183

    CAS  PubMed  Google Scholar 

  30. Duprez E, Benoit G, Flexor F, Lillehaug JR, Lanotte M . A mutated PML/RARα found in the retinoid maturation resistant NB4 subclone, NB4-R2, blocks RARα and wild-type PML/RARα transcriptional activities Leukemia 2000 14: 255–261

    Article  CAS  PubMed  Google Scholar 

  31. Lanotte M, Martin-Thouvenin V, Najman S, Ballerini P, Valensi F, Berger R . NB4, a maturation inducible cell line with t(15;17) marker isolated from human acute promyelocytic leukemia (M3) Blood 1991 77: 1080–1086

    CAS  PubMed  Google Scholar 

  32. De Thé H, Chomienne C, Lanotte M, Degos L, Dejean A . The t(15 ;17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor α gene to a novel transcribed locus Nature 1990 347: 558–561

    Article  PubMed  Google Scholar 

  33. Duprez E, Ruchaud S, Houge G, Martin-Thouvenin V, Valensi F, Kastner Ph, Berger R, Lanotte M . A retinoid acid ‘resistant’ t(15 ;17) acute promyelocytic leukemia cell line: isolation, morphological, immunological and molecular features Leukemia 1992 6: 1281–1287

    CAS  PubMed  Google Scholar 

  34. Ruchaud S, Duprez E, Gendron MC, Houge G, Genieser HG, Jastorff B, Doskeland SO, Lanotte M . Two distinctly regulated events, priming and triggering, during retinoid-induced maturation and resistance of NB4 promyelocytic leukemia cell line Proc Natl Acad Sci USA 1994 91: 8428–8432

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Pendino F, Flexor M, Delhommeau F, Buet D, Lanotte M, Ségal-Bendirdjian E . Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation Proc Natl Acad Sci USA 2001 98: 6662–6667

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Kim N, Piatyszek MA, Prowse K, Harley C, West M, Ho P, Coviello G, Wright W, Weinrich S, Shay J . Specific association of human telomerase activity with immortal cells and cancer Science 1994 266: 2011–2015

    Article  CAS  PubMed  Google Scholar 

  37. Bryan TM, Englezou A, Gupta J, Bachetti S, Reddel RR . Telomere elongation in immortal human cells without detectable telomerase activity EMBO J 1995 14: 4240–4248

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR . Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines Nat Med 1997 3: 1271–1274

    Article  CAS  PubMed  Google Scholar 

  39. Ulaner GA, Hu JF, Vu TH, Giudice LC, Hoffman AR . Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts Cancer Res 1998 58: 4168–4172

    CAS  PubMed  Google Scholar 

  40. Zhang A, Zheng C, Lindvall C, Hou M, Ekedahl J, Lewensohn R, Yan Z, Yang X, Henriksson M, Blennow E, Nordenskjold M, Zetterberg A, Bjorkholm M, Gruber A, Xu D . Frequent amplification of the telomerase reverse transcriptase gene in human tumors Cancer Res 2000 60: 6230–6235

    CAS  PubMed  Google Scholar 

  41. Duprez E, Lillehaug JR, Gaub MP, Lanotte M . Differential changes of receptor (RXRα) and its RARα and PML-RARα partners induced by cAMP and retinoic acid distinguish maturation sensitive and resistant t(15;17) promyelocytic leukemia NB4 cells Oncogene 1996 12: 2443–2450

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by the Institut National de la Santé et de la Recherche Médicale, the Ligue Nationale contre le Cancer and the Association pour la Recherche contre le Cancer (ARC Nos 5384, and 5707). TS and FP were supported by the Coopération Franco-Algérienne, and the Ministère de la Recherche et de la Technologie, respectively. We thank Dr G Chabot (INSERM U496) for critical reading of the manuscript.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pendino, F., Sahraoui, T., Lanotte, M. et al. A novel mechanism of retinoic acid resistance in acute promyelocytic leukemia cells through a defective pathway in telomerase regulation. Leukemia 16, 826–832 (2002). https://doi.org/10.1038/sj.leu.2402470

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402470

Keywords

This article is cited by

Search

Quick links